Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Chris Fair
Florence Barrère de Groot
Katherine Sage
Philippe Saudan
Joost de Bruijn
Daniel Geiger
G. Joseph Ross
John Griffin
Laura Rosa
Marcel Borger
Sjoerd Musters
Board:
Joost de Bruijn
Kimberley Elting
Oliver Walker
Clemens van Blitterswijk
Shareholding in %:
BlackRock Investment Management (UK) Ltd. 1.83
C A C M Oomen 24.79
Deka Investment GmbH 1.83
Janus Henderson Investors UK Ltd. 1.16
Joh. Berenberg, Gossler & Co. KG (Investment Management) 1.89
Pegasus Global Opportunity Fund Ltd. 2.71
Swedbank Robur Fonder AB 1.11
UBS Asset Management Switzerland AG 2.52
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2.97
Zürcher Kantonalbank (Investment Management) 1.57
Freefloat 57.62
Address: Wagistrasse 25, 8952 Schlieren
T: +41-44-733-47-47
F: +41-44-733-47-40
I: http://kurosbio.com
E: info@kuros.ch